SCHEMBL190839

SCHEMBL190839

CCOC(=O)c1ccc(Cl)c(Oc2ccnc(N)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B2 P37059 1/20 0.46
ALDH1A1 P00352 2/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
CYP1A2 P05177 3/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
GPR119 Q8TDV5 1/20 0.41
JMJD6 Q6NYC1 3/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
RAB9A P51151 1/20 0.40
MAPK14 Q16539 1/20 0.40
MET P08581 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL191196 0.88 ALDH1A1 (0.46) HSD17B2ALDH1A1CA12CA1CA2
SCHEMBL2662685 0.80 NOS3 (0.38) HSD17B2ALDH1A1CA12CA1CA2
SCHEMBL190750 0.80 ALDH1A1 (0.42) HSD17B2ALDH1A1CA12CA1CA2
SCHEMBL1330161 0.79 ALDH1A1 (0.47) HSD17B2ALDH1A1CA12CA1CA2
SCHEMBL970395 0.79 ALDH1A1 (0.44) HSD17B2ALDH1A1CA12CA1CA2
SCHEMBL191399 0.79 HSD17B2 (0.45) HSD17B2ALDH1A1CA12CA1CA2
SCHEMBL191022 0.78 GCK (0.44) ALDH1A1LMNARAB9AGAAMAPT
SCHEMBL256755 0.78 GABRP (0.56) HSD17B2CA12CA1CA2CA7
SCHEMBL192504 0.77 GPR119 (0.45) HSD17B2ALDH1A1CA12CA1CA2
Hydrochloric Acid SCHEMBL6740832 0.77 JMJD6 (0.55) HSD17B2CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1986645-B1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC (US) 2012-01-04 EP disclosed
US-8022222-B2 Glucokinase activators ARRAY BIOPHARMA, INC. (US) 2011-09-20 US disclosed
US-20090247526-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2009-10-01 US disclosed
EP-1986645-A1 GLUCOKINASE ACTIVATORS Array Biopharma, Inc. (US) 2008-11-05 EP disclosed
WO-2007089512-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2007-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247526-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 HSD17B2 1686/4885ALDH1A1 1869/4885CA12 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.